Sernova Biotherapeutics Inc
SEOVF
$0.146
$0.00382.67%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.47% | 57.78% | 26.06% | -6.19% | -21.36% |
| Total Depreciation and Amortization | -56.61% | 40.86% | 44.82% | -5.49% | -2.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.76% | -187.18% | -42.08% | -13.14% | 47.99% |
| Change in Net Operating Assets | -97.70% | 434.15% | -25.12% | 407.73% | 138.87% |
| Cash from Operations | -7.94% | 65.62% | 24.13% | 20.09% | 22.47% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -48.98% | 556.03% | -91.33% |
| Cash from Investing | -- | -100.00% | -48.93% | 546.97% | -91.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 1.39% | 3.23% | 1.87% | 1.87% | -0.70% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -256.19% | -- | 16.83% | -- |
| Cash from Financing | 149.06% | 4,016.00% | 159.81% | 35.95% | -114.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -106.33% | 110.91% | -69.77% | 68.75% | -111.80% |